pyrroles has been researched along with Cerebral Arteriosclerosis in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (75.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Z; Feng, Y; Gao, P; Lu, Z; Wang, P; Wang, S; Zhang, G; Zhou, P | 1 |
| Chen, TY; Kuo, YL; Lin, WC; Tan, TY | 1 |
| Goldstein, MR; Mascitelli, L; Pezzetta, F | 1 |
| Deedwania, P; Singh, V | 1 |
| Kasner, SE; Taylor, RA; Weigele, JB | 1 |
| Blanco-Colio, LM; Egido, J; Hernández, G; Martín-Ventura, JL; Martínez, E; Muñoz-García, B; Ortega, L; Ortiz, A; Sánchez, S | 1 |
| Berger, BL; Beuter, MJ; Callahan, AS; Devlin, TG | 1 |
| Callahan, A | 1 |
3 review(s) available for pyrroles and Cerebral Arteriosclerosis
| Article | Year |
|---|---|
Reducing morbidity and mortality in high risk patients with statins.
Topics: Atorvastatin; Cardiovascular Diseases; Cholesterol, LDL; Coronary Disease; Diabetes Complications; Dose-Response Relationship, Drug; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracranial Arteriosclerosis; Kidney Failure, Chronic; Metabolic Diseases; Practice Guidelines as Topic; Pyrroles; Randomized Controlled Trials as Topic; Risk Factors | 2009 |
Current management of symptomatic intracranial stenosis.
Topics: Angioplasty; Anticoagulants; Atorvastatin; Brain; Brain Ischemia; Cilostazol; Constriction, Pathologic; Endovascular Procedures; Fibrinolytic Agents; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracranial Arteriosclerosis; Phosphodiesterase 3 Inhibitors; Platelet Aggregation Inhibitors; Pyrroles; Stents; Stroke; Tetrazoles | 2011 |
Cerebrovascular disease and statins: a potential addition to the therapeutic armamentarium for stroke prevention.
Topics: Anticholesteremic Agents; Atorvastatin; Cerebral Infarction; Cholesterol; Dose-Response Relationship, Drug; Heptanoic Acids; Humans; Intracranial Arteriosclerosis; Prospective Studies; Pyrroles; Randomized Controlled Trials as Topic | 2001 |
1 trial(s) available for pyrroles and Cerebral Arteriosclerosis
| Article | Year |
|---|---|
Efficacy and safety of intensive statin therapy in Chinese patients with atherosclerotic intracranial arterial stenosis: a single-center, randomized, single-blind, parallel-group study with one-year follow-up.
Topics: Aged; Atorvastatin; China; Clinical Protocols; Constriction, Pathologic; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracranial Arteriosclerosis; Ischemic Attack, Transient; Male; Middle Aged; Middle Cerebral Artery; Pyrroles; Single-Blind Method; Stroke; Vertebrobasilar Insufficiency | 2014 |
4 other study(ies) available for pyrroles and Cerebral Arteriosclerosis
| Article | Year |
|---|---|
Effect of lipid-lowering therapy on the progression of intracranial arterial stenosis.
Topics: Aged; Anticholesteremic Agents; Atorvastatin; Cerebral Arteries; Constriction, Pathologic; Disease Progression; Female; Heptanoic Acids; Humans; Hyperlipidemias; Infarction, Middle Cerebral Artery; Intracranial Arteriosclerosis; Male; Middle Aged; Platelet Aggregation Inhibitors; Pyrroles; Secondary Prevention; Sex Distribution; Stroke; Treatment Outcome; Vertebrobasilar Insufficiency | 2009 |
Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study.
Topics: Age Factors; Aged; Atorvastatin; Causality; Cerebral Hemorrhage; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Iatrogenic Disease; Intracranial Arteriosclerosis; Male; Pyrroles; Sex Factors | 2009 |
Fn14 is upregulated in cytokine-stimulated vascular smooth muscle cells and is expressed in human carotid atherosclerotic plaques: modulation by atorvastatin.
Topics: Aged; Aorta; Atorvastatin; Carotid Artery Diseases; Cells, Cultured; Chemokine CCL2; Cytokine TWEAK; Cytokines; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation Mediators; Intracranial Arteriosclerosis; Male; Mevalonic Acid; Middle Aged; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Polyisoprenyl Phosphates; Pyrroles; Receptors, Tumor Necrosis Factor; Recombinant Proteins; rho GTP-Binding Proteins; Tumor Necrosis Factors; TWEAK Receptor; Up-Regulation | 2006 |
Possible short-term amelioration of basilar plaque by high-dose atorvastatin: use of reductase inhibitors for intracranial plaque stabilization.
Topics: Aged; Angioplasty, Balloon; Anticholesteremic Agents; Atorvastatin; Cerebral Angiography; Combined Modality Therapy; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracranial Arteriosclerosis; Male; Neurologic Examination; Pyrroles; Vertebrobasilar Insufficiency | 2001 |